Nrx pharmaceuticals appoints seth van voorhees, phd, as chief financial officer and treasurer

Radnor, pa. , june 7, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp), a clinical-stage biopharmaceutical company, announced today that the company's board of directors appointed seth van voorhees, ph.d.
NRXP Ratings Summary
NRXP Quant Ranking